chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I didn't feel good I was at work; I am a nurse, and I was trying to manage this was day 1 of five rotation. It started with a headache, and I had no appetite and I tried to force it was very bland. I had a peppermint patty, and I couldn't taste it. Then I went to the ER and I felt horrible I was having a hard time to keep my head up and I was sent home and they told me they would send the results. I was unable to walk around I had to crawl. I was so tired, and my body hurt so bad just extreme pain everywhere like in the joints. I thought the pain was because I wasn't sleeping in my bed. I tried to sleep on the floor on the sofa and the chair trying to find a way to get comfortable. I was called at 05:30 PM same day and told me I was positive. I was sent to get antibodies injections and I was given fluid hydration. This didn't help I had an appointment on the 18 of November and was told to go to the ER right away. I was then diagnosed aortic root high blood pressure and COVID lungs and pneumonia. I then prescribed an inhaler and antibiotics which helped. I have hypersensitivity to the body, and I couldn't wear jeans, bras, socks and I still fight with it but it's not as bad. I am also still having a brain fog where I can't recall certain things and I also can't multitask, and I have a hard time having conversations and keeping up. I have joined the COVID recovery program, which is 3 times a week which includes physical, pain, speech therapy. The program was about 8 weeks, but the speech was extended, and my husband passed away and that set me back. I then was given 6 weeks more to help me. I am still currently not working I had an evaluation because of the grief of losing my husband. I was also just told I couldn't go back to nursing after doing this for 28 years. I was also told I need to wear glasses and the treatment is as if I had a brain injury.
urinated blood; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date, as dose 2, single, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date, as dose 1, single, for COVID-19 immunisation. It was reported that, 2 days after receiving his second dose of the Pfier BioNTech COVID-19 vaccine, he urinated blood. It was just one incident and after that it disappeared. The patient followed up with his doctor who told him everything was fine. The patient wanted to know if there were other people who experienced this after the vaccine. The outcome for the event was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My father died 10 days after receiving the vaccine. According to the doctors he was a strong healthy man. How he dropped suddenly and died three days later our family would like to know. He had the one dose Johnson and Johnson vaccine.  The only change in his medical is that his BP was elevated and the doctors said that led to his hemorrhagic  aneurysm causing his death.
Cellulitis, erythema (9x16cm) induration warm and tender to touch.
8 hours post injection developed mild injection site/arm pain and soreness 13 hours post injection developed fever, tax 102.7F, chills/rigors, severe body aches
Pt experienced severe pain in upper and lower extremities. Parents treated with alternating Tylenol and Ibuprofen. Pt was out of school for 3 days. Pain eventually resolved. Per parents pt. also had the same reaction to the flu vaccine in October 2018. Pt experienced pain in upper and lower extremities. Each occurrence had taken 1 to 2 weeks for the pain to subside. Flu vaccine in 2018 was given at Pharmacy.
Redness, soreness, swelling and itching in arm from site of injection toward the elbow covered area about 1 1/2 inches by 3 inches. Period of dizziness. Over 7 days I took a total of 3 TYLENOL, applied 1% HYDROCORISONE jell to relieve itching.
Pt recvd vax Pt exp painful stinging upon inject; the next day of the arm of inject was inflammed; other pts recvd inject form the same lot w/no adverse reactions;
Wild fluctuations on blood pressure; This is a spontaneous report from a Contactable Consumer. A female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 25Sep2021 as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced wild fluctuations on blood pressure. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Rash/whelps to BUE, chest, face and head; No SOB or facial swelling. Treated with PO BENDARYL allowed to sit in office x 3o min. Rash resolved.
This is a spontaneous report from a Non-contactable Other HCP (health care professional).  A 25-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot Number: EN6206, expiration date unknown) 1st dose, via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization (at the age of 25-years-old). The patient medical history and concomitant medications were not reported. Caller stated that, after receiving first dose of vaccine on an unspecified date the patient experienced red blotchy, itchy rash on Left deltoid area x 4-6 days and started feeling itchy over whole body in one hour after injection. The outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.
Patient had negative HCG at time of vaccine administration. Had positive HCG a month later.
death Narrative: I was told that the patient expired 3 days after his 2nd dose of Moderna vaccine.
Patient has shingles on the left lower extremity from the mild post buttocks down to the knee.
Warm; Itchy; Rash around the injection site; It was a little swollen; Painful; The edges are red still but the center is more of a skin like tone; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash around the injection site), VACCINATION SITE SWELLING (It was a little swollen) and VACCINATION SITE PAIN (Painful) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No treatment information was provided.  Concomitant products included BISOPROLOL FUMARATE (PROBIS) for Blood pressure abnormal, ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash around the injection site), VACCINATION SITE SWELLING (It was a little swollen), VACCINATION SITE PAIN (Painful) and VACCINATION SITE ERYTHEMA (The edges are red still but the center is more of a skin like tone). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and IBUPROFEN for Itching, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash around the injection site), VACCINATION SITE SWELLING (It was a little swollen), VACCINATION SITE PAIN (Painful) and VACCINATION SITE ERYTHEMA (The edges are red still but the center is more of a skin like tone) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other treatment information included: cold wash cloth.
Evening of the 10th I was watching TV in bed and noticed I could feel my pulse in my left ear bumping. It was so significant I thought it was an outside sound for a minute. I took my blood pressure was elevated and my heart rate was about 112. My elevated heartrate continued on and off, mostly on, throughout the week, rising above 100. I was anxious during that week, unreasonably so. When I went to the doctor on the 15th I was starting to feel better. Because my nurse practitioner couldn't conclude if it was due to the vaccination or not, I am currently wearing a heart monitor and she also gave me propranolol to take three times a day. I will take the heart monitor off on the 28th, and will follow up on 01/12.
Hives, fever, erythema multiforme ?. Hand/foot edema serum sickness like reaction.
headache; dizzy; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 70-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Right on 12Feb2021 09:00 (Batch/Lot Number: EL8982) as dose 2, single (at age of 70-years old) for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2, solution for injection, via an unspecified route of administration on 22Jan2021 as single dose (at age of 70-years old) for covid-19 immunization. The patient experienced headache and dizzy on 12Feb2021. Therapeutic measures were taken as a result of headache. Caller stated that he got the second dose this morning at 9AM. Wanted to know if he could drink aspirin for a headache. Stated that his headache was bothering him. Stated that he was reading, and it does not say. Stated that he used take aspirin Excedrin sometimes for headache. Stated that he was dizzy. Stated that he has had the headache for one hour. Stated that he did not have a headache in observation. Stated that the headache and dizziness started when he got home. The outcome of the events was not resolved at time of reporting.  No follow-up attempts are possible. No further information is expected.
27 hrs after first vaccination, pain in hips, lower back, slight fever, fatigue, headache
Numbness, paresthesias, burning pain of bilateral legs, left is worse than right. Numbness, paresthesias, burning pain, Deep aching pain of left upper extremity, cold sensation of left arm and left leg. Numbness of the face, paresthesias of the lips, objectively decreased light touch everywhere, but worse in all the areas mentioned.
Pt stated the vaccine gave her a mole at the injection site also complained of arm tenderness, leg numbness, and dropping things.
Bivalent vaccines have undergone several temperature excursions; No adverse event; Bivalent vaccines have undergone several temperature excursions and have been administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions ) and NO ADVERSE EVENT (No adverse event) in a 31-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     It was unknown if patient had ever been diagnosed or tested positive for COVID-19.     On 23-Sep-2022 at 5:43 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 23-Sep-2022 at 5:43 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions ) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions ) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient) and PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions ).    No concomitant product reported by the reporter.  Patient had received previous 3 doses of vaccine, intramuscular with anatomical site as deltoid. Dose 4 anatomical site was also reported as deltoid. Bivalent vaccines stored in the refrigerator that underwent several temperature excursions in August 2022.Refrigeration excursions were identified, state vaccine was housed in the units. There were excursions noted. Manufactures were notified and the state department was made aware of the situation.  No adverse reactions were reported for any of the patients at the time of the report.  No treatment medication reported by the reporter.
Patient reports that evening she started to feel unwell, very fatigued.  She developed a red patch that wrapped around her shoulder (4inches wide by 6-7inches long).  She self treated with ibuprofen.  She felt better after a week.
Off-cycle menstrual bleeding. Initially as spotting (3/26 overnight) and then increased to heavy flow, complete with mild  to moderate cramping (still ongoing on 3/29). Started on day 7 of new cycle after having just completed prior cycle, while taking oral contraceptives.
right lower leg heaviness then weakness that began 3 weeks after vaccine, which then progressed to upper extremity. Gait became unstable eventually using walker and cane. pt had several falls last one june 28, 2021 whereby he sustained a left orbital fracture. in addition some mental fogginess reported as well.
Patient had 2nd Shingrix vaccination on 10/2/19 and experienced an episode of high blood pressure on 10/3/19 (over 200 systolic per patient) which caused her to seek medical attention at urgent care and then subsequently the ER. She followed up with her doctor on 10/4. CT at ER was negative and all labs came back within normal limits per patient. Patient suggested that Shingrix vaccine could be the cause since no other cause was found.
Nurse reported VAQTA was administered after improper storage; unknown of VAQTA was prefilled syringe or vial, however it is known that it was a pediatric dose administered. The operator of the device was a healthcare professional. Requested follow up; This spontaneous report was received from a nurse regarding a patient of unspecified age and gender. Information regarding medical history, concurrent conditions, and concomitant medications was not reported.    The nurse reported on 11-JUL-2023, the patient was vaccinated with 1 dose of Hepatitis A Vaccine, Inactivated (VAQTA) as prophylaxis (lot number X003791 and expiration date 01-JUN-2024 both confirmed as valid) after improper storage (product storage error) (it was unknown by the nurse if the Hepatitis A Vaccine, Inactivated (VAQTA) vaccine was prefilled syringe or vial; however it was internally confirmed to be a vial formulation); it was known that it was a pediatric dose administered. The operator was a healthcare professional.
Patient stated arm was really sore where injection given when did follow up call on 11/3/09.
could not keep balance; could not speak well; could not walk well; could not breath through nose; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of BALANCE DISORDER (could not keep balance), SPEECH DISORDER (could not speak well) and GAIT DISTURBANCE (could not walk well) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 12L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, VALSARTAN (VALSARTAN/HYDROCHLOROTHIAZIDE) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced DYSPNOEA (could not breath through nose). On 16-Feb-2021, the patient experienced BALANCE DISORDER (could not keep balance) (seriousness criterion hospitalization) and SPEECH DISORDER (could not speak well) (seriousness criterion hospitalization). 16-Feb-2021, the patient experienced GAIT DISTURBANCE (could not walk well) (seriousness criterion hospitalization). The patient was hospitalized on 23-Feb-2021 due to BALANCE DISORDER, GAIT DISTURBANCE and SPEECH DISORDER. The patient was treated with Surgery for Balance disorder; Surgery for Speech disorder and Surgery for Gait disturbance. At the time of the report, BALANCE DISORDER (could not keep balance), SPEECH DISORDER (could not speak well), GAIT DISTURBANCE (could not walk well) and DYSPNOEA (could not breath through nose) outcome was unknown.            Treatment included acetaminophen after receiving injection.  911 was called on 23-Feb-2021 and patient taken to a medical center where she was admitted for an unspecified emergency surgery. Patient was on ventilator at time of report.   This case was linked to US-MODERNATX, INC.-MOD-2021-132568 (E2B Linked Report). This case was linked to MOD-2021-132568 (Patient Link).; Sender's Comments: Very limited information regarding this event has been provided at this time. US-MODERNATX, INC.-MOD-2021-132568:Case for first dose
Initial report received from a health care professional (pharmacist) on 20 Aug 2010: On an unspecified date this patient received a 0.5 ml intramuscular dose of expired S-OIV FLUVIRIN (batch number 102149P1) that had an expiration date of 30 Apr 2010. No further information provided at the time of this report. Follow up report received from the health care professional on 14 Sep 2010: The patient was vaccinated with S-OIV FLUVIRIN, 0.5 ml intramuscular in the left deltoid on 19 Aug 2010.
COLD SWEAT; SINUS ISSUE; COLD LIKE SYMPTOMS; INJECTION SITE BRUISING; INJECTION SITE SORENESS; This spontaneous report received from a patient concerned a 54 year old male. The patient's weight was 212 pounds, and height was 71 inches. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. Non-company suspect drugs included: influenza vaccine ( form of admin, route of admin, and batch number were not reported) dose and frequency were not reported from 21-AUG-2021 for flu. No concomitant medications were reported.  On MAR-2021, the patient experienced injection site soreness. On 26-MAR-2021, the patient experienced injection site bruising. On 21-AUG-2021, the patient experienced cold like symptoms. On 21-AUG-2021, the patient experienced sinus issue. On an unspecified date, the patient experienced cold sweat. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site bruising on 14-JUN-2021, cold like symptoms, and sinus issue on 23-AUG-2021, and injection site soreness on JUN-2021, and the outcome of cold sweat was not reported. This report was non-serious.
it was hard to breathe patient went into the doctor; Pleurisy started on Monday dated patient thought it was a pulled muscle.; extreme thumb and wrist pain in patient left wrist; extreme thumb and wrist pain in patient left wrist; This is a spontaneous report from a contactable consumer (reported for himself). A 41-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: ER2613/Batch number was not reported), via an unspecified route of administration, administered in arm left on 16Apr2021 at 00:15 (at the age of 41-years-old) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. It was reported that pleurisy started on Monday 19Apr2021 patient thought it was a pulled muscle. Patient also had extreme thumb and wrist pain in his left wrist started on Monday as well but went away the very next day completely gone just as fast as it appeared so no way it was injury related. Patient thought his chest was getting better on Tuesday 20Apr2021 then when he woke up on Wednesday 21Apr2021 and it was hard to breathe. The reporter stated the events result in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events included treatment with Steroids / Antibiotics. The outcome of the event extreme thumb and wrist pain in patient left wrist was resolved on 20Apr2021 and other events was resolving.  No follow-up attempts are possible. No further information is expected.
Patient experienced upper and lower lip swelling within 24-hours of injection. Has recent history of receiving dermal fillers to area in december 2021
It was discovered on 12/20/2022 that the Moderna vaccine that was administered was expired. Contacted Moderna and was advised that the vaccine was still viable at this time, therefore the vaccine was considered a valid dose, and patient does not need to be re-vaccinated.
She started having breathing problems/heart attack appearance. on 1/22/21 and went to the ER. Upon admittance was told it was an anaphylactic shock from the Covid shot. They kept her in ICU and released her 1/23/21. At 12:45 am on 1/24/21 she passed out and we called the ambulance. Hospital admitted her and worked through multiple organ failure issues and thought her numbers were under control. She was released on 1/27/21 and was driving on 1/28/21 around 4:15 pm and appears to have had heart failure and had a wreck. She passed away that day.
felt the medicine immediately travel into the area of my armpit.  Soreness for 3 days. Insomnia for 2 days. 6 weeks post injection my left arm (shoulder) started going numb and tingling.  Feeling of "dead arm" and heavy arm. Pain that lasted approx 4 -5 days.  Took iron and magnesium supplements which helped.  The same numbness and tingling returned again about 5-6 weeks later.  The supplements didn't help as much the 2nd time.  Symptoms returned again, but I can't remember how far apart the third time, they weren't as strong, and dissipated faster. I did call my Dr after the 2nd time and she recommended an U/S but my insurance isn't good, and it was too far away and too expensive.